A study published in the Journal of Immunology indicates that naturally occurring antibodies in the human immune system have the capacity to suppress inflammatory responses throughout the body. These antibodies may provide researchers an opportunity to develop new therapies for rheumatoid arthritis (RA) and other inflammatory conditions using similar pathways.
Rheum with a View
Panush’s perspectives on selections from the literature
“A Common Language for Spondyloarthritis”
ASAS fills a niche, changes dogma with consensus approach
Arthritis on the Rise
CDC notes significant increase in arthritis-attributable activity limitation
For Myopathy Basic Diagnostic Rules Hold
Rare and challenging, idiopathic inflammatory myopathies are gaining from collaborative research
Research Tracks Possible Benefit of Src-like Adaptor Protein
A study recently submitted for publication has demonstrated that manipulating T-cell receptor complex–mediated signaling can prevent the development of autoimmune arthritis in mice and may lead to new human therapies without the drawbacks associated with existing treatments.
Quadruple-threat Rheumatologist
In Norway and on the international front, Tore Kvien, MD, PhD, has propelled clinical research to new levels
Research on IL-17 Cytokine May Lead to Novel Therapies for RA
Research in the laboratory of John D. Mountz, MD, PhD, is opening up a whole new field of study in rheumatoid arthritis (RA).
Competition on Another Pitch: Capture the World Cup Spirit to Drive Rheumatology Discovery
Capture the World Cup spirit to drive rheumatology discovery
Unique Meeting Accelerates RA Research
More than 50 rheumatoid arthritis (RA) investigators from across the U.S. recently met in Ft. Worth, Texas, to share information, present data and results from their innovative RA research projects, and brainstorm ways to work more closely together to find a cure for the disease.
- « Previous Page
- 1
- …
- 106
- 107
- 108
- 109
- 110
- …
- 127
- Next Page »